{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/61269-381#drug","name":"PYLERA","alternateName":"BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE, AND TETRACYCLINE HYDROCHLORIDE","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"61269-381"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"NDA050786"},{"@type":"PropertyValue","propertyID":"UNII","value":"R3O80H60KX|140QMO216E|P6R62377KV"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"c50626a2-5969-490b-a88a-a4ee45e79615"}],"activeIngredient":"BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE, TETRACYCLINE HYDROCHLORIDE","administrationRoute":["ORAL"],"dosageForm":"CAPSULE","manufacturer":{"@type":"Organization","name":"H2-Pharma, LLC"},"drugClass":[],"isAvailableGenerically":false,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/NDA050786","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c50626a2-5969-490b-a88a-a4ee45e79615","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=61269-381"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-11-03T02:22:40.439Z"}}